BIO-key Reports Strong Q3 Growth Driven by 39% Increase in License Fee Revenue
BIO-key (BKYI) reported strong third-quarter results, highlighted by a significant expansion in its core software business. The company saw license fee revenue grow by 39% year-over-year, which played a critical role in improving overall profitability metrics. The shift toward high-margin recurring revenue has significantly bolstered the company's financial profile, lifting gross margins to 90%, up from 77% in the previous year. Looking ahead, management is targeting profitability as they enter Q1 with approximately $1.2 million in projected license renewals.
Tickers: $BKYI
Topics: earnings report gross margin revenue growth software business
Read the full article at Seeking Alpha
Part of the story BIO KEY INTERNATIONAL INC - 8-K Filing (2 articles)